Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction on a Missing Ferroelectric Butterfly Phosphorus Allotrope and Its Energy-Favorable Low-Dimensional Forms.

The journal of physical chemistry letters·2025
Same author

Phylogenetic Relationship and Characterization of the Complete Mitochondrial Genome of the Cuckoo Species <i>Clamator coromandus</i> (Aves: Cuculidae).

International journal of molecular sciences·2025
Same author

A Computational Framework Analysis of Public Attitudes Toward Male Human Papillomavirus Infection and Its Vaccination in China: Based on Weibo Data.

Healthcare (Basel, Switzerland)·2025
Same author

Harnessing near-infrared and Raman spectral sensing and artificial intelligence for real-time monitoring and precision control of bioprocess.

Bioresource technology·2025
Same author

Risk Factors, Microbiology, and Prognosis of Diabetic Foot Osteomyelitis: A Retrospective Cohort Study.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Proton minibeam (pMBRT) radiation therapy: experimental validation of Monte Carlo dose calculation in the RayStation TPS.

Physics in medicine and biology·2025

相关实验视频

Updated: May 3, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K

通过时空优化优化优化正常组织的节约,在同等的瘤根基疗效下.

Nimita Shinde1, Wangyao Li1, Ronald C Chen1

  • 1Department of Radiation Oncology, University of Kansas Medical Center, USA.

ArXiv
|September 15, 2025
PubMed
概括

这项研究引入了一种用于放射治疗的新型时空优化模型. 它确保了足够的瘤剂量,同时最大限度地减少了风险器官的剂量,优化了基于瘤生长动态的辐射分成.

科学领域:

  • 辐射瘤学 辐射瘤学
  • 医学物理 医学物理
  • 计算生物学 计算生物学

背景情况:

  • 传统的辐射疗法优化最大限度地提高了瘤剂量,但可能会损害瘤的死亡.
  • 时空优化平衡剂量递送 (分数) 和每分数的剂量.
  • 有风险的器官 (OAR) 约束对于尽量减少毒性至关重要.

研究的目的:

  • 为辐射疗法开发一个时空优化模型.
  • 确保足够的生物有效剂量 (BED) 杀死瘤细胞.
  • 为了最大限度地减少BED传递给OARs,考虑到瘤增殖动态.

主要方法:

  • 一个新的时空优化模型是用不平等约束来制定的.
  • 该模型结合了瘤滞后时间和翻倍时间,以优化剂量分量.
  • 对质子疗法进行了实施,评估了各种扩散参数的性能.

主要成果:

  • 该模型始终实现了杀死瘤细胞所需的最低BED.
  • 平均BED到OAR随着瘤扩散动态 (延迟和翻倍时间) 变化.
  • 确定了最佳分成策略,不同的是前列腺 (例如,大腿骨头) 和头部病例.
关键词:
强度调制的质子疗法 (IMPT)空间时间优化优化生物有效剂量 (BED)

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K

相关实验视频

Last Updated: May 3, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K

结论:

  • 拟议的模型有效地将OAR剂量降至最低,同时确保足够的瘤剂量.
  • 结合瘤生长动力学 (延迟和翻倍时间) 优化了分化.
  • 这种多功能模型可以支持高级分成策略,如高分成和加速分成.